Redeye: Ranplan - The strong growth continues
Ranplan's Q2 report marked the second consecutive quarter with significant sales growth (230% y/y) and positive results. We have updated our model following the report, which brings an increased fair value range.
Read more and download the research update: http://bit.ly/33Fm8Ws
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/